EFFECT OF PROSTAGLANDIN-E(1) ON PRESERVATION INJURY OF CANINE LIVER GRAFTS PRESERVED IN UW SOLUTION

被引:1
作者
TAKAHASHI, K [1 ]
YAMAMOTO, N [1 ]
EGAWA, H [1 ]
TAKEUCHI, T [1 ]
YAMAGUCHI, T [1 ]
TAKADA, Y [1 ]
NISHIZAWA, F [1 ]
TAKAYASU, T [1 ]
NARITA, M [1 ]
MORI, K [1 ]
YAMAOKA, Y [1 ]
OZAWA, K [1 ]
机构
[1] KYOTO UNIV,FAC MED,DEPT SURG 2,54 KAWARA CHO,SAKYO KU,KYOTO 606,JAPAN
关键词
PRESERVATION; LIVER; CANINE; LIVER TRANSPLANTATION; PROSTAGLANDIN-E(1); LIVER PRESERVATION; UW SOLUTION;
D O I
10.1007/BF00336022
中图分类号
R61 [外科手术学];
学科分类号
摘要
This study investigated whether prostaglandin E1 (PGE1) could reduce hepatic injury to the liver graft caused by harvesting and 24-h preservation in University of Wisconsin (UW) solution in a canine model. The PGE1-treated group was intravenously administered 0.5 mug/kg per minute of PGE1 for 30 min before harvesting, as well as a concentration of 1 mg/l PGE, in the washout and UW solutions. In both the PGE1-treated and the control group, all recipients survived for 1 week or more after transplantation. Arterial ketone body ratio (AKBR) remained over 1.0 in the early postoperative period. The PGE, group showed significant reductions in guanase, GOT, and LDH during the early postoperative period compared to the untreated control group. Histological examination disclosed partial mitochondrial swelling, hepatocyte vacuolation, and necrosis in the control group, while such abnormalities were rarely seen in the PGE, group. These results suggest that PGE1 can effectively reduce hepatic injury to liver grafts preserved in UW solution prior to transplantation.
引用
收藏
页码:245 / 250
页数:6
相关论文
共 30 条
  • [1] Asonuma K., Tanaka K., Uemoto S., Okamura R., Matsuoka S., Kitakado Y., Utsunomiya H., Katayama T., Tanaka M., Inomata Y., Ozawa K., Changes in blood ketone body ratio with reference to graft viability after liver transplantation in rats, Transpl Int, 2, pp. 133-136, (1989)
  • [2] Asonuma K., Takaya S., Selby R., Okamoto R., Yamamoto R., Yokoyama T., Todo S., Ozawa K., Starzl T.E., The clinical significance of the arterial ketone body ratio as an early indicator of graft viability in human liver transplantation, Transplantation, 51, pp. 164-171, (1991)
  • [3] Ferguson W.W., Edmonds A.W., Starling J.R., Wangensteen S.L., Protective effect of prostaglandin E<sub>1</sub> (PGE<sub>1</sub>) on lysosomal enzyme release in serotonin-induced gastric ulceration, Ann Surg, 177, pp. 648-654, (1973)
  • [4] Furukawa H., Todo S., Imventarza O., Wu Y.M., Scotti C., Day R., Starzl T.E., Cold ischemia time vs outcome of human liver transplantation using UW solution, Transplant Proc, 23, pp. 1550-1551, (1991)
  • [5] Gaber A.O., Thistlethwaite J.R., Busse-Henry S., Aboushloe M., Emond J., Rouch D., Broelsch C.E., Improved results of preservation of hepatic grafts preflushed with albumin and prostaglandins, Transplant Proc, 20, pp. 992-993, (1988)
  • [6] Greig P.D., Woolf G.M., Sinclair S.B., Abecassis M., Strasberg S.M., Taylor B.R., Blendis L.M., Superina R.A., Glynn M.F.X., Langer B., Levy G.A., Treatment of primary liver graft nonfunction with prostaglandin E<sub>1</sub>, Transplantation, 48, pp. 447-453, (1989)
  • [7] Howard T.K., Klintmalm G.B.G., Cofer J.B., Husberg B.S., Goldstein R.M., Gonwa T.A., The influence of preservation injury on rejection in the hepatic transplant recipient, Transplantation, 49, pp. 103-107, (1990)
  • [8] Inagawa T., Miyamoto S., Radioimmunoassay for measurement of prostaglandins, Advances in prostaglandin, thromboxane, and leukotriene research, vol. 15, pp. 75-77, (1985)
  • [9] Jamieson N.V., Sundberg R., Lindell S., Claesson K., Moen J., Vreugdenhil P.K., Wight D.G.D., Southard J.H., Belzer F.O., Preservation of the canine liver for 24–48 hours using simple cold storage with UW solution, Transplantation, 46, pp. 517-522, (1988)
  • [10] Kalayoglu M., Sollinger H.W., Stratta R.J., D'Alessandro A.M., Hoffmann R.M., Prishi J.D., Belzer F.O., Extended preservation of the liver for clinical transplantation, Lancet, 1, pp. 617-619, (1988)